Home > Products > doxorubicin & EGFR > Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (IgG-scFv)

Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (IgG-scFv)  (CAT#: IGFV-151)

Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (IgG-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can be used in pretargeting system and deliver toxin to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Datasheet INQUIRY

Specifications

Targets
doxorubicin & EGFR
Type
IgG-scFv
Species Reactivity
Human
Application
FuncS; Pretargeting system for toxin delivery
Related Disease
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors

Targets

Target 1
doxorubicin
Alternative Names
doxorubicin
Target 2
EGFR
Gene ID
UniProt ID
Alternative Names
EGFR; epidermal growth factor receptor; ERBB; HER1; mENA; ERBB1; PIG61; NISBD2; proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; erb-b2 receptor tyrosine kinase 1; cell proliferation-inducing protein 61; receptor tyrosine-protein kinase erbB-1; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "doxorubicin & EGFR"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-doxorubicin x Anti-EGFR Bispecific Antibody (IgG-scFv) (IGFV-151). Click the button below to contact us or submit your feedback about this product.